Peptide Decoding
New?New to peptides?Start here →
Decoding

VIP (Vasoactive Intestinal Peptide)_Dosage, benefits & legal status

Also known as vasoactive intestinal peptide, aviptadil, VIP

Published July 22, 2026 · Updated August 14, 2026

A nasal-spray peptide used to calm chronic inflammation and immune problems.

Immune & inflammationNeuropeptideResearch only
Common vial size10 mg
Dose0.05 mg per dose
FrequencySeveral daily
RouteNasal spray
StatusResearch only
CycledNo established schedule

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is VIP (Vasoactive Intestinal Peptide)?

Plain language first. The technical label stays, but it never stands alone.

Overview

It relaxes blood vessels and airways and calms the immune system. A nasal spray form is used to try to quiet chronic inflammation. It can also lower blood pressure.

The technical version

VIP (vasoactive intestinal peptide) is a natural 28-amino-acid signaling peptide found in the gut, lungs, and nerves.

What it's used for

A nasal-spray peptide used to calm long-term inflammation and immune problems, popular in mold-illness protocols.

02

How does VIP (Vasoactive Intestinal Peptide) work?

What it does in the body, and where.

VIP is a 28-amino-acid signaling peptide your gut, lungs, and nerves already produce. The nasal form is used off-label for chronic inflammatory conditions.

  1. 01
    It relaxes blood vessels and airways
    The 'vasoactive' in the name, and its original identified function.
  2. 02
    It calms immune signaling
    Shifting immune cells away from an inflammatory state, which is the basis for its use in chronic inflammatory response syndrome.
  3. 03
    The nasal route is deliberate
    VIP is destroyed almost immediately in the bloodstream, so it is sprayed rather than injected.
  4. 04
    Its main use is off-label and contested
    The mould-illness protocols it appears in are not accepted by mainstream medicine, and the peptide's evidence should not be confused with the protocol's.
Anatomical illustration highlighting lungs
WHERE THIS COMPOUND IS THOUGHT TO ACT:
LungsGut

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Sarcoidosis and lung inflammationInvestigational
  • Chronic inflammatory response syndrome and mold illness, which is the main reason people seek it outResearch only
  • Severe COVID lung failure, where a large trial found no benefitInvestigational

The published record

Research index

73

Papers and trials about VIP (Vasoactive Intestinal Peptide)

Searched: vasoactive intestinal peptide administration, aviptadil, inhaled vasoactive intestinal peptide, vasoactive intestinal peptide therapy, VIP nasal spray.

Left out: VIP (too short to disambiguate without context); VIP (too short to disambiguate without context).

32 papers tagged human · 15 not reviews or lab · 5 clinical trial publications

9 registered trials · 3 with posted results

Furthest stage reached: Phase 3, results posted

Compare this against the whole library →

Category 1Regulators
In animals9
In the lab1
Reviews8
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

VIP (Vasoactive Intestinal Peptide) vial rendering
Compound field notes

At a glance

Four things to know about VIP (Vasoactive Intestinal Peptide)

01

Evidence

Research only

02

Category

Healing and recovery

03

Common vial

10 mg

04

Half-life

About 1 minute

04

How much, and do you cycle it?

The range, and whether you take breaks.

0.05 mg per dose, several daily. No established schedule No range

No published study has established how long to take this or whether a break is needed. Schedules quoted online come from vendors and forums, and different sources disagree.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

About 1 minuteHuman study

One of the shortest in the library. A second study describes two phases, about 2 minutes and about 21 minutes.

Source: Domschke S, et al. Gut 1978, PMID 730072. Second human study, PMID 16435487

You can compare this against the whole library to see where it sits.

06

What does it cost?

Typical dose and cost, in plain numbers.

The products priced here are not injected

Route: nasal spray.

Cost per month
—
Cost per dose
—
Typical dose
50 mcg / doseCommunity practice
No published human study establishes this dose. It comes from vendor and community practice, and several compounds in this group share suspiciously identical round numbers across retailer sites.
What it costs

VIP (Vasoactive Intestinal Peptide) starts at $25.00 across 87 vendors, typically $5.00 – $11.90 per mg.

104 listings, last read Oct 24, 2026. Shipping and card fees are not included.

See all 104 listings →
07

How do you store it?

Before mixing, and after.

Fridge after opening. Use within about 30 days.

Store sealed VIP (Vasoactive Intestinal Peptide) in the fridge. Once opened, keep it upright in the fridge and plan to finish it inside roughly 30 days. Keep it out of light and do not freeze the liquid.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 32% charged residues, 36% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • Low blood pressure, since it widens blood vessels
  • No formal contraindications established

Stop and get help

These are emergencies. Seek care.
  • Feeling faint or very dizzy, which can signal a blood-pressure drop
  • Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing

Common effects

Expected, and usually mild.
  • Diarrhea
  • A drop in blood pressure, which is the main known effect
  • In a large COVID trial it was stopped for lack of benefit, not for safety problems

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is VIP (Vasoactive Intestinal Peptide) approved?

And where the numbers on this page come from.

No. VIP (Vasoactive Intestinal Peptide) is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Nasal spray
  • Checked
    22 July 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

What regulators say

From official documents
10

What else is like VIP (Vasoactive Intestinal Peptide)?

Others in Healing and recovery, side by side.

If you're weighing VIP (Vasoactive Intestinal Peptide), it's worth reading Cartalax, Cortagen, and Livagen in the same class.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 73 records are indexed. Browse the records